VitaNova Life Sciences (VNOV) Depreciation & Amortization (CF) (2017 - 2018)

VitaNova Life Sciences (VNOV) reported Depreciation & Amortization (CF) of -$2367.0 for Q4 2018, down 246.29% on a YoY basis from $1618.0 in Q4 2017, and down 200.0% quarter-over-quarter from $2367.0 in Q3 2018.

VitaNova Life Sciences (VNOV) Depreciation & Amortization (CF) (2017 - 2018) Analysis & Trends

VitaNova Life Sciences has reported Depreciation & Amortization (CF) for 2 years, with the latest figure at -$2367.0 in Q4 2018.

  • For the quarter ending Q4 2018, Depreciation & Amortization (CF) fell 246.29% year-over-year to -$2367.0; the trailing twelve-month figure through Jul 2019 stood at -$2367.0 (down 159.4% YoY), and the FY2018 full-year result was $2848.0, up 7020.0% from the prior year.
  • Depreciation & Amortization (CF) for Q4 2018 stood at -$2367.0, down from $2367.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $2367.0 in Q3 2018, with the low at -$2367.0 in Q4 2018.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Akso Health 2,315,158.81 Bn 2,315,158.63 Bn - -
2 Mckesson 92.76 Bn 89.18 Bn 4.04 Bn 67.00 Mn
3 Cencora 52.82 Bn 50.83 Bn 3.59 Bn 142.30 Mn
4 Cardinal Health 52.17 Bn 48.39 Bn 2.50 Bn 248.00 Mn
5 Henry Schein 9.19 Bn 9.71 Bn 1.07 Bn 81.00 Mn
6 Accendra Health 246.88 Mn -90.00 Mn 312.39 Mn 61.74 Mn
7 Edap Tms 161.92 Mn 146.92 Mn 8.15 Mn 896,000.00
8 111 107.47 Mn 25.61 Mn 23.58 Mn -
9 Cosmos Health 9.42 Mn 7.26 Mn 1.38 Mn 346,520.00
10 VitaNova Life Sciences - - 316,343.00 -

Historic Data

Download Data
DateValue
Oct 31, 2018 -2,367.00
Oct 31, 2018 -2,367.00
Jul 31, 2018 2,367.00
Jul 31, 2018 2,367.00
Oct 31, 2017 1,618.00
Oct 31, 2017 1,618.00
Jul 31, 2017 120.00
Jul 31, 2017 120.00